Bulletin
Investor Alert

Perrigo Co. PLC

NYS: PRGO

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 6, 2021, 5:29 p.m.

/zigman2/quotes/201110862/composite

$

37.04

Change

0.00 0.00%

Volume

Volume 32,098

Quotes are delayed by 20 min

/zigman2/quotes/201110862/composite

Today's close

$ 35.79

$ 37.04

Change

+1.25 +3.49%

Day low

Day high

$36.04

$38.04

Open

52 week low

52 week high

$35.34

$50.90

Open

Svend D. Andersen

Svend D. Andersen is EVP & President-Consumer Selfcare International at Perrigo Co. Plc.

In his past career he occupied the position of President-EMEA & Vice President at Hospira, Inc., Vice President-Commercial Operations at Ferrosan ApS, Executive Vice President-Europe Region at LEO Pharma A, Executive Vice President-Europe at LEO Laboratories Ltd. (Ireland), Vice President & General Manager-EMEA at Zoetis Products LLC and Executive Vice President-Western Europe Sales at Actavis, Inc.

Svend D. Andersen received an undergraduate degree from Copenhagen Business School.

Transactions

Date Shares Transaction Value
03/08/2021 47   Derivative/Non-derivative trans. at $41.82 per share. 1,966
03/08/2021 5,543   Award at $41.82 per share. 231,808
03/05/2021 55   Derivative/Non-derivative trans. at $41.04 per share. 2,257
03/05/2021 2,540   Derivative/Non-derivative trans. at $41.04 per share. 104,241
03/05/2021 37   Derivative/Non-derivative trans. at $41.04 per share. 1,519
03/05/2021 2,960   Derivative/Non-derivative trans. at $41.04 per share. 121,478
08/11/2020 2,828   Acquisition at $53.01 per share. 149,912
03/06/2020 3,565   Derivative/Non-derivative trans. at $53.17 per share. 189,552
03/06/2020 5,982   Award at $53.17 per share. 318,062
03/06/2020 885   Derivative/Non-derivative trans. at $53.17 per share. 47,056
03/06/2020 1,485   Award at $53.17 per share. 78,957
03/06/2020 1,764   Derivative/Non-derivative trans. at $53.17 per share. 93,792
03/06/2020 2,960   Derivative/Non-derivative trans. at $53.17 per share. 157,383
10/08/2019 3,538   Derivative/Non-derivative trans. at $51.94 per share. 183,764
10/08/2019 7,527   Derivative/Non-derivative trans. at $51.94 per share. 390,952
11/09/2018 3,900   Acquisition at $63.01 per share. 245,739
08/14/2018 7,200   Acquisition at $69.43 per share. 499,896

Officers and Executives

Mr. Murray S. Kessler
President, Chief Executive Officer & Director
Mr. Raymond P. Silcock
CFO, Principal Accounting Officer & Executive VP
Mr. Thomas M. Farrington
Chief Information Officer & Executive VP
Dr. Grainne Quinn
Chief Medical Officer & Executive Vice President
Mr. Adrian Innergård
General Manager-Northern Europe
Ms. Sharon Kochan
EVP, President-RX Pharmaceuticals
Mr. Svend D. Andersen
EVP & President-Consumer Selfcare International
Mr. Ronald C. Janish
Chief Transformation Officer
Mr. James E. Dillard
President-CSCA & Executive Vice President
Mr. Louis K. Cherico
Treasurer & Vice President
Mr. Bradley Joseph
Vice President-Global Investor Relations
Mr. Robert Willis
Chief Human Resources Officer & Executive VP
Mr. Todd W. Kingma
Secretary, Executive VP & General Counsel
Mr. Rolf Allan Classon
Chairman
Ms. Katherine C. Doyle
Independent Director
Mr. Orlando D. Ashford
Independent Director
Mr. Donal M. O'Connor
Independent Director
Mr. Geoffrey M. Parker
Independent Director
Mr. Theodore Rapp Samuels
Independent Director
Mr. Bradley A. Alford
Independent, Director
Mr. Jeffrey B. Kindler
Independent Director
Ms. Adriana Karaboutis
Independent Director
Ms. Erica L. Mann
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.